Stock DNA
Pharmaceuticals & Biotechnology
CNY 4,608 Million (Small Cap)
13.00
NA
3.36%
-0.06
9.45%
1.52
Revenue and Profits:
Net Sales:
916 Million
(Quarterly Results - Dec 2025)
Net Profit:
30 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.94%
0%
-1.94%
6 Months
-2.69%
0%
-2.69%
1 Year
-2.79%
0%
-2.79%
2 Years
-4.98%
0%
-4.98%
3 Years
-12.16%
0%
-12.16%
4 Years
-14.9%
0%
-14.9%
5 Years
15.02%
0%
15.02%
Zhuzhou Qianjin Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.04%
EBIT Growth (5y)
1.79%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
1.31
Tax Ratio
8.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.21%
ROE (avg)
15.82%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.78
EV to EBIT
13.98
EV to EBITDA
9.92
EV to Capital Employed
1.95
EV to Sales
1.12
PEG Ratio
NA
Dividend Yield
3.56%
ROCE (Latest)
13.94%
ROE (Latest)
13.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
916.20
905.40
1.19%
Operating Profit (PBDIT) excl Other Income
139.90
87.80
59.34%
Interest
0.00
0.00
Exceptional Items
0.00
1.60
-100.00%
Consolidate Net Profit
29.60
89.20
-66.82%
Operating Profit Margin (Excl OI)
152.70%
65.10%
8.76%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 1.19% vs -11.20% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -66.82% vs -42.60% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,634.60
3,591.50
1.20%
Operating Profit (PBDIT) excl Other Income
440.50
401.40
9.74%
Interest
0.00
8.50
-100.00%
Exceptional Items
0.00
3.60
-100.00%
Consolidate Net Profit
287.80
302.60
-4.89%
Operating Profit Margin (Excl OI)
121.20%
78.20%
4.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.20% vs -4.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -4.89% vs -23.39% in Dec 2024
About Zhuzhou Qianjin Pharmaceutical Co., Ltd. 
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






